Navigation Links
Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
Date:6/8/2009

al," said Jeffrey Stein, Ph.D., Chief Executive Officer of Trius. "Later this year we will complete Phase 1 testing of the IV dosage form of torezolid and plan to merge the oral and IV programs in Phase 3 testing early next year. Our aim is to make torezolid available to physicians and patients as soon as possible to address the growing unmet medical need for an effective and well tolerated new IV and oral treatment for drug-resistant infections."

About Torezolid (TR-701)

Torezolid is a second-generation IV/oral antibacterial drug in the oxazolidinone class. It is significantly differentiated from Zyvox(R) (linezolid), the only marketed drug in this class. Advantages of torezolid over linezolid include:

  • 4-8 fold greater potency than linezolid in vitro and in vivo
  • In vivo bactericidal activity
  • Activity against all clinically important, gram-positive, drug-resistant strains including those resistant to linezolid
  • Activity against clinically important atypical and gram-negative pathogens (Legionella, Chlamydia, Neisseria)
  • 16x lower rate of resistance development in MRSA
  • Once-daily and shorter course of therapy to promote better treatment compliance
  • Broader safety window enabling potential longer course of therapy
  • Possibility for expanded indications including bacteremia, severe CAP and osteomyelitis
  • Lower potential for drug-drug interactions including those with dietary tyramine, SSRIs and vasoconstrictors

About Trius Therapeutics

Trius Therapeutics is discovering and developing innovative antibacterial drugs for the treatment of infections caused by drug-resistant pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity agai
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
2. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
3. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
4. Trius Doses First Patient in Antibacterial Phase 2 Trial
5. PacificGMP Completes GMP Product Fill for Trius Therapeutics
6. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
7. Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
8. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
9. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
10. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
11. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Nov. 21, 2014   Long Beach dentist , Dr. ... called the gold standard in tooth replacement because they offer ... long-lasting way to restore and preserve smiles and improve overall ... a missing tooth or as a part of a smile ... and feel of a smile. The loss of ...
(Date:11/22/2014)... ORLANDO, Fla. , Nov. 21, 2014 MEDITE ... 2014 reported nine months and the 3 rd quarter ... million. Operating income was $448,000 for the nine months ended ... September 2014. "Even though our 3 rd quarter is ... period which extends from July into September for many countries ...
(Date:11/22/2014)... , Nov. 21, 2014 Research and ... Recombinant Protein Drug Industry Report, 2014-2017" report to ... The Chinese recombinant protein drug market has ... rigidity, consumption ability and the like. During 2005-2013, sales ... grew at a CAGR of 19.1%, and it is ...
Breaking Medicine Technology:Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
(Date:11/24/2014)... (PRWEB) November 24, 2014 Abington ... Ternopolska, MD has joined The Neurology Group and ... Multiple Sclerosis Center. , A graduate of Vinnica ... Neurology at Albert Einstein Medical Center in Philadelphia and ... Jaffe Multiple Sclerosis Center at Weill Cornell Medical College. ...
(Date:11/24/2014)... Recently, SweetDressy.com, a well-known dress supplier and leader ... 2014 Evening Dresses. All these fresh items are offered ... manager, the special offer is valid until Dec. 20, ... has been working well in the fashion industry for ... Their new dresses may be the best products for ...
(Date:11/24/2014)... The typical American diet includes foods that are ... a diet high in calories and carbohydrates only enables ... typically accumulate around the internal organs exposing people to ... the form of love handles, beer bellies and thunder ... rid themselves of the burden of embarrassing, unhealthy and ...
(Date:11/24/2014)... November 24, 2014 Dr. Michael Kettel ... Center, recently appeared on NBC to discuss egg freezing as ... has been trending in the news recently, with new company ... for women. , “[The companies] see it as ... on a career hot path.” Says Dr. Kettel. , Up ...
(Date:11/23/2014)... 24, 2014 For the coming special ... has launched a great promotion for many products, especially ... can get the best choice with amazing discounts, up ... Tidebuy.com. , It is easy to buy colored ... that, this selection is also famous for delicate craftsmanship, ...
Breaking Medicine News(10 mins):Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2
... Cell phone distractions account for more than 300,000 car crashes each ... to limit or prohibit the use of things like cell phones ... University finds a widening gap between the evidence on distracted driving ... new study, published this month in the American Journal of ...
... -- Patients with bipolar disorder may be eligible ... medications -- quetiapine (Seroquel), a widely prescribed second-generation ... stabilizer. NewYork-Presbyterian Hospital/Weill Cornell Medical Center is ... only site in the greater New York metropolitan ...
... By Steven Reinberg HealthDay Reporter , ... recommend antibiotics for asthma, almost 1 million children with ... in the United States, a new study finds. ... this suggests that we as pediatricians are prescribing them ...
... of tuberculosisas well as in the practices, programs and ... human immunodeficiency virus (HIV)the spread of multidrug-resistant (MDR) tuberculosis ... Research in the June issue of The Journal ... of 18F-FDG positron emission tomography (PET) scans can help ...
... immobilise radioactive forms of iodine using a microwave, has been ... Iodine radioisotopes are produced by fission of uranium fuel in ... it is highly mobile in the environment and selective uptake ... following long term exposure. Furthermore, iodine-129, which is a type ...
... , MONDAY, May 23 (HealthDay News) -- Are you the type ... theater? If so, here,s some good news: A new Norwegian study ... in better health than those who don,t. Both men and ... health and satisfaction with life than those who were less engaged. ...
Cached Medicine News:Health News:Temple-led study finds widening gap between distracted driving and legislation 2Health News:New study aims to improve long-term treatment for patients with bipolar disorder 2Health News:Too Many Kids Getting Antibiotics for Asthma 2Health News:Too Many Kids Getting Antibiotics for Asthma 3Health News:PET scans predict effectiveness of treatment for multidrug-resistant tuberculosis in HIV patients 2Health News:Expert discovers simple method of dealing with harmful radioactive iodine 2Health News:A Cultured Man Is a Healthier, Happier Man: Study 2Health News:A Cultured Man Is a Healthier, Happier Man: Study 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: